[Preventive measures against postoperative secondary aldosteronism following open heart surgery--planned administration of injective aldosterone antagonist].
Shirakura
R
R
Hirose
H
H
Nakano
S
S
Matsuda
H
H
Ohtani
M
M
Taniguti
H
H
Nomura
H
H
Kawashima
Y
Y
D000328:Adult; D000368:Aged; D002191:Canrenoic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D006348:Cardiac Surgical Procedures; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000517:prevention & control*; D006947:Hyperkalemia / Q000139:chemically induced; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D011183:Postoperative Complications / Q000517:prevention & control*; D011292:Premedication; D011300:Preoperative Care
D000451:Mineralocorticoid Receptor Antagonists; D002191:Canrenoic Acid